Essential Thrombocythemia
Showing NaN - NaN of 9
Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)
Recruiting
- Essential Thrombocythemia
- Ropeginterferon alfa-2b
- Anagrelide
-
Phoenix, Arizona
- +60 more
Dec 30, 2021
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +4 more
-
Scottsdale, Arizona
- +21 more
Jan 18, 2021
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:
Completed
- Polycythemia Vera
- +2 more
-
Salt Lake City, UtahUniversity of Utah
Oct 14, 2019
Research Tissue Bank
Completed
- Myelofibrosis
- +3 more
-
Palo Alto, California
- +10 more
Jul 2, 2019
Patients With Myeloproliferative Disorders
Completed
- Myeloproliferative Disease
- +4 more
-
Scottsdale, Arizona
- +21 more
Dec 12, 2018
Familial Myeloproliferative Disorders
Completed
- Polycythemia Vera
- +2 more
-
Washington, D.C., District of Columbia
- +5 more
Sep 1, 2017
Myeloproliferative Tumors of, Polycythemia Vera, Essential Thrombocythemia Trial in United States (LY2784544)
Completed
- Myeloproliferative Neoplasms of
- +3 more
-
Birmingham, Alabama
- +8 more
Apr 10, 2017
Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera Trial in United States (CEP-701 (Lestaurtinib))
Unknown status
- Myelofibrosis
- +2 more
- CEP-701 (Lestaurtinib)
-
Palo Alto, California
- +6 more
Nov 24, 2014